nct_id,nlm_download_date_description,intervention_type,intervention_name,description,status,facility_name,city,state,zip,country,site_count
NCT04244591,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,methylprednisolone therapy,Methylprednisolone 40 mg q12h for 5 days,Recruiting,"Medical ICU,Peking Union Medical College Hospital",Beijing,Beijing,10,China,1
NCT04244591,"ClinicalTrials.gov processed this data on February 25, 2020",Other,Standard care,Standard care,Recruiting,"Medical ICU,Peking Union Medical College Hospital",Beijing,Beijing,10,China,1
NCT04252118,"ClinicalTrials.gov processed this data on March 06, 2020",Biological,MSCs,"3 times of MSCs(3.0*10E7 MSCs intravenously at Day 0, Day 3, Day 6).",Recruiting,Beijing 302 Military Hospital of China,Beijing,,100039,China,1
NCT04251871,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,"Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules","Conventional medicines: oxygen therapy, antiviral therapy (alfa interferon via aerosol inhalation, and lopinavir/ritonavir, 400mg/100mg, p.o, bid) for 14 days.
Traditional Chinese Medicines (TCMs) granules: 20g, p.o, bid, for 14 days.",Recruiting,"The Fifth Medical Center, General Hospital of PLA",Beijing,Beijing,100039,China,1
NCT04251871,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,"Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)","Conventional medicines: oxygen therapy, antiviral therapy (alfa interferon via aerosol inhalation, and lopinavir/ritonavir, 400mg/100mg, p.o, bid) for 14 days.",Recruiting,"The Fifth Medical Center, General Hospital of PLA",Beijing,Beijing,100039,China,1
NCT04252274,"ClinicalTrials.gov processed this data on March 13, 2020",Drug,Darunavir and Cobicistat,"Subjects take darunavir and cobicistat one tablet per day for 5 days, also take conventional treatments",Recruiting|Recruiting,Shanghai Public Health Clinical Center|Shanghai Public Health Clinical Center,Shanghai|Shanghai,Shanghai|Shanghai,201508|,China|China,2
NCT04252885,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,Lopinavir and Ritonavir Tablets,As indicated in arm/group descriptions,Recruiting,Guangzhou Eighth People's Hospital,Guangzhou,Guangdong,510060,China,1
NCT04252885,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,Arbidol,As indicated in arm/group descriptions,Recruiting,Guangzhou Eighth People's Hospital,Guangzhou,Guangdong,510060,China,1
NCT04251767,"ClinicalTrials.gov processed this data on March 23, 2020",Other,washed microbiota transplantation,"Washed microbiota suspension (5u) delivered through nasogastric tube, nasojejunal tube or oral.
Dose and frequency: 5u, once.",,"Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University",Nanjing,Jiangsu,210011,China,1
NCT04251767,"ClinicalTrials.gov processed this data on March 23, 2020",Other,placebo,"Placebo (edible suspension of the same color as the washed microbiota suspensionï¼Œ5u) administered via nasogastric tube, nasojejunal tube or oral, combining with standard therapy.
Dose and frequency: 5u, once.",,"Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University",Nanjing,Jiangsu,210011,China,1
NCT04257656,"ClinicalTrials.gov processed this data on March 05, 2020",Drug,Remdesivir,"RDV 200 mg loading dose on day 1 is given, followed by 100 mg iv once-daily maintenance doses for 9 days.",Recruiting,Bin Cao,Beijing,Beijing,100029,China,1
NCT04257656,"ClinicalTrials.gov processed this data on March 05, 2020",Drug,Remdesivir placebo,"RDV placebo 200 mg loading dose on day 1 is given, followed by 100 mg iv once-daily maintenance doses for 9 days.",Recruiting,Bin Cao,Beijing,Beijing,100029,China,1
NCT04252664,"ClinicalTrials.gov processed this data on March 05, 2020",Drug,Remdesivir,"RDV 200 mg loading dose on day 1 is given, followed by 100 mg iv once-daily maintenance doses for 9 days.",Recruiting,Jin Yin-tan hospital,Wu Han,Hubei,100013,China,1
NCT04252664,"ClinicalTrials.gov processed this data on March 05, 2020",Drug,Remdesivir placebo,"RDV placebo 200 mg loading dose on day 1 is given, followed by 100 mg iv once-daily maintenance doses for 9 days.",Recruiting,Jin Yin-tan hospital,Wu Han,Hubei,100013,China,1
NCT04263402,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Methylprednisolone,"Patients in the Group I will receive basic symptomatic supportive treatment,plus methylprednisolone(<40mg/d intravenous drip for 7 days).",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04263402,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Methylprednisolone,"Patients in the Group II will receive basic symptomatic supportive treatment,plus methylprednisolone(40~80mg/d intravenous drip for 7 days).",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04255017,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Abidol hydrochloride,"Abidol hydrochloride (0.2g once, 3 times a day,2 weeks)was added on the basis of group I.",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04255017,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Oseltamivir,"Oseltamivir(75mg once, twice a day,2 weeks) was added on the basis of group I.",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04255017,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Lopinavir/ritonavir,"Lopinavir/ritonavir (500mg once, twice a day,2 weeks)was added on the basis of group I.",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04254874,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Abidol hydrochloride,"0.2g once, 3 times a day,two weeks",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04254874,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Abidol Hydrochloride combined with Interferon atomization,"Abidol Hydrochloride:0.2g once, 3 times a day,two weeks; Interferon(PegIFN-Î±-2b) atomization:45ug, add to sterile water 2ml, twice a day,two weeks",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04264533,"ClinicalTrials.gov processed this data on March 19, 2020",Drug,VC,12g Vitamin C will be infused in the experimental group twice a day for 7 days by the infusion pump with a speed of 12ml/h.,Recruiting,Zhongnan Hospital of Wuhan University,Wuhan,Hubei,430000,China,1
NCT04264533,"ClinicalTrials.gov processed this data on March 19, 2020",Drug,Sterile Water for Injection,50ml sterile water for injection will be infused in the placebo comparator group twice a day for 7 days by the infusion pump with a speed of 12ml/h.,Recruiting,Zhongnan Hospital of Wuhan University,Wuhan,Hubei,430000,China,1
NCT04261270,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,ASC09F+Oseltamivir,"ASC09F tablets:one tablet(400mg/tablet)twice a day for 14 days;Oseltamivir tablet:75mg,once a day",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04261270,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Ritonavir+Oseltamivir,"Ritonavir tablet:three tablets(100mg/tablet)twice a day for 14 days;Oseltamivir tablet:75mg,once a day",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04261270,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Oseltamivir,"75mg ,once a day",Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04261517,"ClinicalTrials.gov processed this data on March 13, 2020",Drug,Hydroxychloroquine,"Subjects take hydroxychloroquine 400 mg per day for 5 days, also take conventional treatments",Recruiting|Recruiting,Shanghai Public Health Clinical Center|Shanghai Public Health Clinical Center,Shanghai|Shanghai,Shanghai|Shanghai,201508|,China|China,2
NCT04261907,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,ASC09/ritonavir group,"ASC09/ritonavir(300mg/100mg tablet), one tablet each time, twice daily, for 14 days, +conventional standardized treatment",NA,NA,NA,NA,NA,NA,NA
NCT04261907,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,lopinavir/ritonavir group,"Lopinavir/ritonavir tablets(200mg / 50mg tablet), two tablets each time, twice daily, for 14 days, +conventional standardized treatment",NA,NA,NA,NA,NA,NA,NA
NCT04260594,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,Arbidol,"Arbidol tablets: take 2 tablets/time, 3 times/day for 14-20 days",NA,NA,NA,NA,NA,NA,NA
NCT04260594,"ClinicalTrials.gov processed this data on February 25, 2020",Other,basic treatment,basic treatment,NA,NA,NA,NA,NA,NA,NA
NCT04275245,"ClinicalTrials.gov processed this data on February 28, 2020",Drug,Meplazumab for Injection,humanized MAb against CD147,Recruiting,Tangdu Hospital,Xi'an,Shaanxi,710032,China,1
NCT04269525,"ClinicalTrials.gov processed this data on February 27, 2020",Biological,UC-MSCs,"After enrollment, each subject will receive UC-MSCs infusion intravenously on day 1, day 3, day 5, and day 7.",Recruiting,Zhongnan Hospital of Wuhan University,Wuhan,Hubei,430000,China,1
NCT04268537,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,PD-1 blocking antibody+standard treatment,"After randomization, PD-1 blocking antibody 200mg iv, one time. Standard treatment is according to the protocol of treatment of 2019-nCoV infection",NA,NA,NA,NA,NA,NA,NA
NCT04268537,"ClinicalTrials.gov processed this data on February 25, 2020",Drug,Thymosin+standard treatment,"Thymosin 1.6 mg sc qd, last for 5 days. Standard treatment is according to the protocol of treatment of 2019-nCoV infection",NA,NA,NA,NA,NA,NA,NA
NCT04268537,"ClinicalTrials.gov processed this data on February 25, 2020",Other,standard treatment,Standard treatment is according to the protocol of treatment of 2019-nCoV infection,NA,NA,NA,NA,NA,NA,NA
NCT04264858,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Immunoglobulin of cured patients,"0.2g/kg, ivdrip, once a day, for 3 days",,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Wuhan,Hubei,430022,China,1
NCT04264858,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Î³-Globulin,"0.2g/kg, ivdrip, once a day, for 3 days",,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Wuhan,Hubei,430022,China,1
NCT04282902,"ClinicalTrials.gov processed this data on March 06, 2020",Drug,pirfenidone,"Pirfenidone is administered orally 3 times a day, 2 tablets each time, for a period of 4 weeks or longer",Recruiting,Tongji hospital affiliated to huazhong university of science and technology,Wuhan,Hubei,,China,1
NCT04276688,"ClinicalTrials.gov processed this data on March 09, 2020",Drug,Lopinavir/ritonavir,400mg/100mg twice daily for 14 days,Recruiting,"University of Hong Kong, Queen Mary Hospital",Hong Kong,,,Hong Kong,1
NCT04276688,"ClinicalTrials.gov processed this data on March 09, 2020",Drug,Ribavirin,400mg twice daily for 14 days,Recruiting,"University of Hong Kong, Queen Mary Hospital",Hong Kong,,,Hong Kong,1
NCT04276688,"ClinicalTrials.gov processed this data on March 09, 2020",Drug,Interferon Beta-1B,0.25mg subcutaneous injection alternate day for 3 days,Recruiting,"University of Hong Kong, Queen Mary Hospital",Hong Kong,,,Hong Kong,1
NCT04280224,"ClinicalTrials.gov processed this data on March 02, 2020",Biological,NK Cells,twice a week of NK cells (0.1-2*10E7 cells/kg body weight),Recruiting,The First Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan,453000,China,1
NCT04275414,"ClinicalTrials.gov processed this data on February 28, 2020",Drug,Bevacizumab Injection,"Bevacizumab 500mg + normal saline (NS) 100ml, ivdrip â‰¥90min",Recruiting,Qilu Hospital of Shandong University,Jinan,Shandong,250012,China,1
NCT04273646,"ClinicalTrials.gov processed this data on March 02, 2020",Biological,UC-MSCs,"4 times of UC-MSCs(0.5*10E6 UC-MSCs/kg body weight intravenously at Day 1, Day 3, Day 5, Day 7).",,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Wuhan,Hubei,430000,China,1
NCT04273646,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,Placebo,"4 times of cell-free stem cell suspension (saline containing 1% human albumin) intravenously at Day 1, Day 3, Day 5, Day 7).",,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Wuhan,Hubei,430000,China,1
NCT04273581,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,placebo,100mg/dï¼Œqnï¼Œfor 14 days.,NA,NA,NA,NA,NA,NA,NA
NCT04273581,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,Thalidomide,100mg/dï¼Œqnï¼Œfor 14 days.,NA,NA,NA,NA,NA,NA,NA
NCT04273529,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,thalidomide,100mgï¼Œpoï¼Œqnï¼Œfor 14 days.,NA,NA,NA,NA,NA,NA,NA
NCT04273529,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,placebo,100mgï¼Œpoï¼Œqnï¼Œfor 14 days.,NA,NA,NA,NA,NA,NA,NA
NCT04304313,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Sildenafil citrate tablets,0.1g/day for 14 days,Recruiting,Department and Institute of Infectious Disease,Wuhan,Hubei,430030,China,1
NCT04273763,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Bromhexine Hydrochloride Tablets,Bromhexine Hydrochloride Tablets,,The Second AffIliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,325000,China,1
NCT04273763,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Arbidol Hydrochloride Granules,Standard treatment refers to the latest edition of Pneumonia Diagnosis and Treatment Scheme for Novel Coronavirus Infection. Arbidol Hydrochloride Granules is recommended but not enforced to use.,,The Second AffIliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,325000,China,1
NCT04273763,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Recombinant Human Interferon Î±2b Spray,Standard treatment refers to the latest edition of Pneumonia Diagnosis and Treatment Scheme for Novel Coronavirus Infection.,,The Second AffIliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,325000,China,1
NCT04293887,"ClinicalTrials.gov processed this data on March 13, 2020",Drug,Recombinant human interferon Î±1Î²,Saline needle 2ml + recombinant human interferon Î±1Î²10ug bid nebulization inhalation,NA,NA,NA,NA,NA,NA,NA
NCT04273321,"ClinicalTrials.gov processed this data on March 05, 2020",Drug,Methylprednisolone,Methylprednisolone 1mg/kg/day ivgtt for 7 days.,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,Hubei province hospital of integrated Chinese & Western Medicine|Yichang first people's Hospital|Renmin Hospital of Wuhan University|Tianyou Hospital Affiliated to Wuhan University of science and technology|Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology,Wuhan|Yichang|Wuhan|Wuhan|Wuhan,Hubei|Hubei|||,||||,China|China|China|China|China,5
NCT04279197,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,N-acetylcysteine+ Fuzheng Huayu Tablet,The subjects will be taking 1 N-acetylcysteine capcule and 4 Fuzheng Huayu tablets three times a day for 24 weeks.,Recruiting,Shuguang Hospital,Shanghai,Shanghai,201203,China,1
NCT04279197,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,N-acetylcysteine+Placebo,The subjects will be taking 1 N-acetylcysteine capcule and 4 Placebo tablets three times a day for 24 weeks.,Recruiting,Shuguang Hospital,Shanghai,Shanghai,201203,China,1
NCT04276987,"ClinicalTrials.gov processed this data on March 06, 2020",Biological,MSCs-derived exosomes,"5 times aerosol inhalation of MSCs-derived exosomes (2.0*10E8 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5).",NA,NA,NA,NA,NA,NA,NA
NCT04275388,"ClinicalTrials.gov processed this data on February 28, 2020",Drug,Xiyanping injection,"Xiyanping injection, 10-20ml daily, Qd, the maximum daily does not exceed 500mg (20mL) + Lopinavir tablet or Ritonavir tablet+Alpha-interferon nebulization, for 7-14 days,",NA,NA,NA,NA,NA,NA,NA
NCT04275388,"ClinicalTrials.gov processed this data on February 28, 2020",Drug,"Lopinavir / ritonavir, alpha-interferon nebulization","Lopinavir / ritonavir tablets, 2 times a day, 2 tablets at a time; alpha-interferon nebulization",NA,NA,NA,NA,NA,NA,NA
NCT04276896,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs,"Patients will receive approximately 5x10^6 LV-DC vaccine and 1x10^8 CTLs via sub-cutaneous injections and iv infusions, respectively.",Recruiting|Recruiting|Recruiting,Shenzhen Geno-immune Medical Institute|Shenzhen Second People's Hospital|Shenzhen Third People's Hospital,Shenzhen|Shenzhen|Shenzhen,Guangdong|Guangdong|Guangdong,518000|518000|518000,China|China|China,3
NCT04278963,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,YinHu QingWen Decoction,"YinHu QingWen Decoction (Granula) consits of 11 Chinese herbal medicine as Honeysuckle, Polygonum cuspidatum, Schizonepeta, Longspur epimedium, etc. The decoction granula will be dissolved into 600ml decoction and divided to 3 times (once with 200ml). It will be given a 200ml per time, three times a day, for 10 days.",||,Jingzhou Hospital of Traditional Chinese Medicine|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University|Xiangyang Hospital of Traditional Chinese Medicine,Jingzhou|Wuhan|Xiangyang,Hubei|Hubei|Hubei,434000|430200|441000,China|China|China,3
NCT04278963,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,YinHu QingWen Decoction(low dose),"This intervention is given as 10% dose of YinHu QingWen Decoction (Granula).The granula will be dissolved into 600ml decoction and divided to 3 times (once with 200ml). It will be given a 200ml per time, three times a day, for 10 days.",||,Jingzhou Hospital of Traditional Chinese Medicine|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University|Xiangyang Hospital of Traditional Chinese Medicine,Jingzhou|Wuhan|Xiangyang,Hubei|Hubei|Hubei,434000|430200|441000,China|China|China,3
NCT04278963,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Chinese medicine treatment,This intervention will be given with Chinese medicine decoction granula based on the symptoms differentiation of the patients for 10 days.,||,Jingzhou Hospital of Traditional Chinese Medicine|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University|Xiangyang Hospital of Traditional Chinese Medicine,Jingzhou|Wuhan|Xiangyang,Hubei|Hubei|Hubei,434000|430200|441000,China|China|China,3
NCT04278963,"ClinicalTrials.gov processed this data on March 23, 2020",Other,standard western medicine treatment,Standard western medicine treatment is according to the protocol of treatment of CoVID-19 infection according to guideline appoved by National Health Commission of China.,||,Jingzhou Hospital of Traditional Chinese Medicine|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University|Xiangyang Hospital of Traditional Chinese Medicine,Jingzhou|Wuhan|Xiangyang,Hubei|Hubei|Hubei,434000|430200|441000,China|China|China,3
NCT04285190,"ClinicalTrials.gov processed this data on March 06, 2020",Drug,T89,"The subjects in the T89 treatment group will receive 30 pills of T89 orally, bid., for 10 days, except a standard background treatment (antiviral drug + antibacterial + oxygen therapy+ Traditional Chinese Medicine decoction). The subjects in the blank control group will only receive a standard background treatment.",NA,NA,NA,NA,NA,NA,NA
NCT04281693,"ClinicalTrials.gov processed this data on March 05, 2020",Diagnostic Test,Standard screening strategy,The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by individual testing.,,the Fifth Medical Center of Chinese PLA General Hospital,Beijing,Beijing,100071,China,1
NCT04281693,"ClinicalTrials.gov processed this data on March 05, 2020",Diagnostic Test,New screening strategy,The pharyngeal swab specimen was obtained and sent for NCIP RNA detection by minipool testing.,,the Fifth Medical Center of Chinese PLA General Hospital,Beijing,Beijing,100071,China,1
NCT04280588,"ClinicalTrials.gov processed this data on March 02, 2020",Drug,Fingolimod 0.5 mg,"Each patient in the fingolimod treatment group was given 0.5 mg of fingolimod orally once daily, for three consecutive days",Recruiting,Wan-Jin Chen,Fuzhou,,,China,1
NCT04280705,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Placebo,The supplied matching placebo lyophilized formulation is identical in physical appearance to the active lyophilized formulation and contains the same inactive ingredients.,Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Not yet recruiting,"University of California San Diego Health - Jacobs Medical Center|University of California Irvine Medical Center - Infectious Disease|University of California Davis Medical Center - Internal Medicine - Infectious Disease|Emory Vaccine Center - The Hope Clinic|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore|Johns Hopkins Hospital - Medicine - Infectious Diseases|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine|Saint Louis University - Center for Vaccine Development|University of Nebraska Medical Center - Infectious Diseases|Montefiore Medical Center - Infectious Diseases|University of Texas Medical Branch - Division of Infectious Disease|Baylor College of Medicine - Molecular Virology and Microbiology|EvergreenHealth Infectious Disease Service|The University of Washington - Virology Research Clinic|Providence Sacred Heart Medical Center|Seoul National University Bundang Hospital - Division of Infectious Diseases|Seoul National University Hospital|National Centre for Infectious Diseases (NCID)",La Jolla|Orange|Sacramento|Decatur|Annapolis|Baltimore|Bethesda|Minneapolis|Saint Louis|Omaha|Bronx|Galveston|Houston|Kirkland|Seattle|Spokane|Bundang-gu Seongnam-si|Seoul|Singapore,California|California|California|Georgia|Maryland|Maryland|Maryland|Minnesota|Missouri|Nebraska|New York|Texas|Texas|Washington|Washington|Washington|Gyeonggi-do|Jongno-gu|,29037|92868-3298|95817-1460|30030-1705|21401-1527|21287-0005|20892-1504|55455-0341|63104-1015|68198-5400|10467-2401|77555-0435|77030-3411|98034|98104-2433|99204|13620|03080|308442,"United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Korea, Republic of|Korea, Republic of|Singapore",19
NCT04280705,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Remdesivir,"Drug Remdesivir is a single diastereomer monophosphoramidate prodrug designed for the intracellular delivery of a modified adenine nucleoside analog GS-441524. In addition to the active ingredient, the lyophilized formulation of Remdesivir contains the following inactive ingredients: water for injection, sulfobutylether beta-cyclodextrin sodium (SBECD), and hydrochloric acid and/or sodium hydroxide.",Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Not yet recruiting,"University of California San Diego Health - Jacobs Medical Center|University of California Irvine Medical Center - Infectious Disease|University of California Davis Medical Center - Internal Medicine - Infectious Disease|Emory Vaccine Center - The Hope Clinic|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore|Johns Hopkins Hospital - Medicine - Infectious Diseases|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine|Saint Louis University - Center for Vaccine Development|University of Nebraska Medical Center - Infectious Diseases|Montefiore Medical Center - Infectious Diseases|University of Texas Medical Branch - Division of Infectious Disease|Baylor College of Medicine - Molecular Virology and Microbiology|EvergreenHealth Infectious Disease Service|The University of Washington - Virology Research Clinic|Providence Sacred Heart Medical Center|Seoul National University Bundang Hospital - Division of Infectious Diseases|Seoul National University Hospital|National Centre for Infectious Diseases (NCID)",La Jolla|Orange|Sacramento|Decatur|Annapolis|Baltimore|Bethesda|Minneapolis|Saint Louis|Omaha|Bronx|Galveston|Houston|Kirkland|Seattle|Spokane|Bundang-gu Seongnam-si|Seoul|Singapore,California|California|California|Georgia|Maryland|Maryland|Maryland|Minnesota|Missouri|Nebraska|New York|Texas|Texas|Washington|Washington|Washington|Gyeonggi-do|Jongno-gu|,29037|92868-3298|95817-1460|30030-1705|21401-1527|21287-0005|20892-1504|55455-0341|63104-1015|68198-5400|10467-2401|77555-0435|77030-3411|98034|98104-2433|99204|13620|03080|308442,"United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Korea, Republic of|Korea, Republic of|Singapore",19
NCT04287686,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Recombinant human angiotensin-converting enzyme 2 (rhACE2),"In this study, the experimental group will receive 0.4 mg/kg rhACE2 IV BID for 7 days.",,GCP Office of The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,510120,China,1
NCT04283461,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,mRNA-1273,"Lipid nanoparticle (LNP) dispersion containing an mRNA that encodes for the prefusion stabilized spike protein 2019-nCoV. mRNA-1273 consists of an mRNA Drug Substance that is manufactured into LNPs composed of the proprietary ionizable lipid, SM-102, and 3 commercially available lipids, cholesterol, DSPC, and PEG2000 DMG.",Not yet recruiting|Recruiting,Emory Children's Center - Pediatric Infectious Diseases|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases,Decatur|Seattle,Georgia|Washington,30030-1705|98101-1466,United States|United States,2
NCT04283838,"ClinicalTrials.gov processed this data on March 23, 2020",Behavioral,Humanistic Care,Psychological and physical rehabilitation based humanistic care regimen,NA,NA,NA,NA,NA,NA,NA
NCT04283825,"ClinicalTrials.gov processed this data on March 23, 2020",Behavioral,Psychological and physical rehabilitation based humanistic care,"This Psychological and physical rehabilitation based humanistic care regimen is generated from the experience of the National medical team members in Wuhan, from our hospital. In addition to the routine therapy, we will apply this comprehensive humanistic care regimen to the patients according to their condition. The patients will be stratified by the severity and receive different combinations of Psychological and physical rehabilitation activities.",NA,NA,NA,NA,NA,NA,NA
NCT04303299,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Oral,Anti virus treatment,,Assistant Professor Subsai Kongsaengdao,Bangkok,,10400,Thailand,1
NCT04293692,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,UC-MSCs,"0.5*10E6 UC-MSCs /kg body weight suspended in 100mL saline containing 1% human albumin intravenously at Day1, Day3, Day5, Day7",,Puren Hospital Affiliated to Wuhan University of Science and Technology,Wuhan,Hubei,430081,China,1
NCT04293692,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Placebo,"100mL saline containing 1% human albumin intravenously at Day 1, Day 3, Day 5, Day 7",,Puren Hospital Affiliated to Wuhan University of Science and Technology,Wuhan,Hubei,430081,China,1
NCT04288102,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,MSCs,"3 times of MSCs(4.0*10E7 cells per time) intravenously at Day 0, Day 3, Day 6.",Recruiting|Recruiting,Maternal and Child Hospital of Hubei Province|Wuhan Huoshenshan Hospital,Wuhan|Wuhan,Hubei|Hubei,430000|430000,China|China,2
NCT04288102,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,Saline containing 1% Human serum albuminï¼ˆsolution of MSCï¼‰,"3 times of placeboï¼ˆintravenously at Day 0, Day 3, Day 6ï¼‰",Recruiting|Recruiting,Maternal and Child Hospital of Hubei Province|Wuhan Huoshenshan Hospital,Wuhan|Wuhan,Hubei|Hubei,430000|430000,China|China,2
NCT04286503,"ClinicalTrials.gov processed this data on March 06, 2020",Drug,Carrimycin,Carrimycin,NA,NA,NA,NA,NA,NA,NA
NCT04286503,"ClinicalTrials.gov processed this data on March 06, 2020",Drug,lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate,lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate,NA,NA,NA,NA,NA,NA,NA
NCT04286503,"ClinicalTrials.gov processed this data on March 06, 2020",Drug,basic treatment,basic treatment,NA,NA,NA,NA,NA,NA,NA
NCT04291729,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Ganovo+ritonavir+/-Interferon atomization,"Ganovo one tablet (100mg / tablet) at a time, twice a day, up to 14 days. Ritonavir one tablet(100mg / tablet) at a time, twice a day, up to 14 days.With or without spray inhalation of interferon, 50Î¼g / time for adults, twice a day up to 14 days.",Recruiting,The Ninth Hospital of Nanchang,Nanchang,Jiangxi,330000,China,1
NCT04291729,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Long acting interferon,"Pegasys 180 Î¼g, subcutaneous injection once a week.",Recruiting,The Ninth Hospital of Nanchang,Nanchang,Jiangxi,330000,China,1
NCT04291729,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Recombinant cytokine gene-derived protein,"Spray inhalation of Novaferon, 20 Î¼g, twice a day, up to 14 days.",Recruiting,The Ninth Hospital of Nanchang,Nanchang,Jiangxi,330000,China,1
NCT04291729,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Lopinavir+ritonavir,"Lopinavir/ritonavir, 200 mg / 50 mg, per tablet, oral, 2 tablets at a time, twice a day, up to 14 days.",Recruiting,The Ninth Hospital of Nanchang,Nanchang,Jiangxi,330000,China,1
NCT04291729,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Chinese medicines +interferon atomization,"Chinese medicines , up to 14 days.Spray inhalation of interferon, 50Î¼g / time for adults, twice a day up to 14 days.",Recruiting,The Ninth Hospital of Nanchang,Nanchang,Jiangxi,330000,China,1
NCT04290871,"ClinicalTrials.gov processed this data on March 16, 2020",Drug,Nitric Oxide Gas,"Inspired NO will be delivered at 80 parts per million (ppm) in the first 48 hours of enrollment. After that, NO levels will be decreased to 40 ppm until severe hypoxia resolves. Weaning from NO will start when patients improves the level of oxygenation to a PaO2/FiO2 > 300 mmHg or SpO2 > 93% for more than 24 hours consecutively. Physician will follow their own institutional weaning protocols. In the absence of institutional protocols, NO will be reduced every 4 hours in step-wise fashion starting from 40 ppm to 20, 10, 5, 3, 2 and 1 ppm.",NA,NA,NA,NA,NA,NA,NA
NCT04302519,"ClinicalTrials.gov processed this data on March 19, 2020",Biological,Dental pulp mesenchymal stem cells,"On the basis of clinical standard treatment, the injection of dental mesenchymal stem cells was increased on day 1, 3 and 7 of the trial.",NA,NA,NA,NA,NA,NA,NA
NCT04290858,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Nitric Oxide,"Nitric Oxide (NO) will be delivered together with the standard of care for a period of 20-30 minutes 2 times per day for 14 consecutive days from time of enrollment. Targeted concentration will have a tidal oscillation between 100 and 300 ppm, in order to maintain an average inhaled concentration from 140 to 180 ppm. The gas will be delivered through a CPAP circuit ensuring an end-expiratory pressure between 2 and 10 cmH2O or trough a non-rebreathing mask without positive end expiratory pressure, depending on the clinical needs of the patient.",NA,NA,NA,NA,NA,NA,NA
NCT04291053,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Huaier Granule,standard treatment + Huaier Granule 20g po tid for 2weeks,NA,NA,NA,NA,NA,NA,NA
NCT04299152,"ClinicalTrials.gov processed this data on March 23, 2020",Combination Product,Stem Cell Educator-Treated Mononuclear Cells Apheresis,"SCE therapy circulates a patient's blood through a blood cell separator, briefly cocultures the patient's immune cells with adherent CB-SC in vitro, and returns the ""educated"" autologous immune cells to the patient's circulation.",NA,NA,NA,NA,NA,NA,NA
NCT04292899,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Remdesivir,Administered as an intravenous infusion,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Hoag Memorial Hospital Presbyterian|Stanford Hospital|University of Chicago|Brigham & Women's Hospital and Harvard Medical School|The Miriam Hospital|Providence Regional Medical Center Everett|Swedish Center for Comprehensive Care|Prince of Wales Hospital|Princess Margaret Hospital|Queen Mary Hospital|Kyungpook National University Hospital|Seoul Medical Center|National Medical Center|National University Hospital|Singapore General Hospital|National Centre for Infectious Diseases, Tan Tock Seng Hospital|National Taiwan University Hospital",Newport Beach|Stanford|Chicago|Boston|Providence|Everett|Seattle|Hong Kong|Hong Kong|Hong Kong|Daegu|Seoul|Seoul|Singapore|Singapore|Singapore|Taipei City,California|California|Illinois|Massachusetts|Rhode Island|Washington|Washington||||||||||,92658|94305|60637|02115|02906|98201|98104||||41944|02053|04564|119228|169856|308442|10002,"United States|United States|United States|United States|United States|United States|United States|Hong Kong|Hong Kong|Hong Kong|Korea, Republic of|Korea, Republic of|Korea, Republic of|Singapore|Singapore|Singapore|Taiwan",17
NCT04292899,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Standard of Care,Standard of care therapy per local written policies or guidelines,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Hoag Memorial Hospital Presbyterian|Stanford Hospital|University of Chicago|Brigham & Women's Hospital and Harvard Medical School|The Miriam Hospital|Providence Regional Medical Center Everett|Swedish Center for Comprehensive Care|Prince of Wales Hospital|Princess Margaret Hospital|Queen Mary Hospital|Kyungpook National University Hospital|Seoul Medical Center|National Medical Center|National University Hospital|Singapore General Hospital|National Centre for Infectious Diseases, Tan Tock Seng Hospital|National Taiwan University Hospital",Newport Beach|Stanford|Chicago|Boston|Providence|Everett|Seattle|Hong Kong|Hong Kong|Hong Kong|Daegu|Seoul|Seoul|Singapore|Singapore|Singapore|Taipei City,California|California|Illinois|Massachusetts|Rhode Island|Washington|Washington||||||||||,92658|94305|60637|02115|02906|98201|98104||||41944|02053|04564|119228|169856|308442|10002,"United States|United States|United States|United States|United States|United States|United States|Hong Kong|Hong Kong|Hong Kong|Korea, Republic of|Korea, Republic of|Korea, Republic of|Singapore|Singapore|Singapore|Taiwan",17
NCT04292730,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Remdesivir,Administered as an intravenous infusion,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Hoag Memorial Hospital Presbyterian|Stanford Hospital|University of Chicago|Brigham & Women's Hospital and Harvard Medical School|The Miriam Hospital|Providence Medical Research Center|Swedish Center for Comprehensive Care|Prince of Wales Hospital|Princess Margaret Hospital|Queen Mary Hospital|Kyungpook National University Hospital|Seoul Medical Center|National Medical Center|National University Hospital|Singapore General Hospital|National Centre for Infectious Diseases, Tan Tock Seng Hospital|National Taiwan University Hospital",Newport Beach|Stanford|Chicago|Boston|Providence|Everett|Seattle|Hong Kong|Hong Kong|Hong Kong|Daegu|Seoul|Seoul|Singapore|Singapore|Singapore|Taipei City,California|California|Illinois|Massachusetts|Rhode Island|Washington|Washington||||||||||,92658|94305|60637|02115|02906|98201|98104||||41944|02053|04564|119228|169856|308442|10002,"United States|United States|United States|United States|United States|United States|United States|Hong Kong|Hong Kong|Hong Kong|Korea, Republic of|Korea, Republic of|Korea, Republic of|Singapore|Singapore|Singapore|Taiwan",17
NCT04292730,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Standard of Care,Standard of care therapy per local written policies or guidelines,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Hoag Memorial Hospital Presbyterian|Stanford Hospital|University of Chicago|Brigham & Women's Hospital and Harvard Medical School|The Miriam Hospital|Providence Medical Research Center|Swedish Center for Comprehensive Care|Prince of Wales Hospital|Princess Margaret Hospital|Queen Mary Hospital|Kyungpook National University Hospital|Seoul Medical Center|National Medical Center|National University Hospital|Singapore General Hospital|National Centre for Infectious Diseases, Tan Tock Seng Hospital|National Taiwan University Hospital",Newport Beach|Stanford|Chicago|Boston|Providence|Everett|Seattle|Hong Kong|Hong Kong|Hong Kong|Daegu|Seoul|Seoul|Singapore|Singapore|Singapore|Taipei City,California|California|Illinois|Massachusetts|Rhode Island|Washington|Washington||||||||||,92658|94305|60637|02115|02906|98201|98104||||41944|02053|04564|119228|169856|308442|10002,"United States|United States|United States|United States|United States|United States|United States|Hong Kong|Hong Kong|Hong Kong|Korea, Republic of|Korea, Republic of|Korea, Republic of|Singapore|Singapore|Singapore|Taiwan",17
NCT04295551,"ClinicalTrials.gov processed this data on March 13, 2020",Drug,Lopinavir / ritonavir tablets combined with Xiyanping injection,"Xiyanping injection, 10-20ml daily, Qd, the maximum daily does not exceed 500mg (20mL) + Lopinavir tablet or Ritonavir tablet+Alpha-interferon nebulization, for 7-14 days,",NA,NA,NA,NA,NA,NA,NA
NCT04295551,"ClinicalTrials.gov processed this data on March 13, 2020",Drug,Lopinavir/ritonavir treatment,"Lopinavir / ritonavir tablets, 2 times a day, 2 tablets at a time; alpha-interferon nebulization",NA,NA,NA,NA,NA,NA,NA
NCT04296643,"ClinicalTrials.gov processed this data on March 13, 2020",Device,Medical Mask,Medical Mask (known also as Surgical Mask),NA,NA,NA,NA,NA,NA,NA
NCT04296643,"ClinicalTrials.gov processed this data on March 13, 2020",Device,N95 respirator,N95 respirator,NA,NA,NA,NA,NA,NA,NA
NCT04308317,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Tetrandrine,Tetrandrine 60mg QD for 1week,,Tetrandrine Tablets,Jinhua,Zhejiang,321000,China,1
NCT04299724,"ClinicalTrials.gov processed this data on March 18, 2020",Biological,Pathogen-specific aAPC,The subjects will receive three injections of 5x10^6 each Covid-19/aAPC vaccine via subcutaneous injections.,Recruiting,Shenzhen Geno-immune Medical Institute,Shenzhen,Guangdong,518000,China,1
NCT04304053,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Antiviral treatment and prophylaxis,"darunavir 800 mg / cobicistat 150 mg tablets (oral, 1 tablet q24h, taking for 7 days) and hydroxychloroquine (200mg tablets) 800mg on day 1, and 400mg on days 2,3,4.
Contacts will be offered a prophylactic regimen of hydroxychloroquine (200mg tablets) 800mg on day 1, and 400mg on days 2,3,4.",NA,NA,NA,NA,NA,NA,NA
NCT04304053,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Standard Public Health measures,Isolation of patient and contact tracing as per national guidelines.,NA,NA,NA,NA,NA,NA,NA
NCT04303507,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Chloroquine,A loading dose of 10 mg base/ kg followed by 150 mg daily (250mg chloroquine phosphate salt) will be taken for 3 months,NA,NA,NA,NA,NA,NA,NA
NCT04303507,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Placebo,Placebo,NA,NA,NA,NA,NA,NA,NA
NCT04306055,"ClinicalTrials.gov processed this data on March 20, 2020",Other,Questionnaire with precaution information,Ever blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.,NA,NA,NA,NA,NA,NA,NA
NCT04306055,"ClinicalTrials.gov processed this data on March 20, 2020",Other,Experimental: Questionnaire without precaution information,Ever blood donors in this group would receive a questionnaire which dose not include the information above.,NA,NA,NA,NA,NA,NA,NA
NCT04305106,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Bevacizumab,"Bevacizumab 500mg + 0.9% NaCl 100ml, intravenous drip",,Qilu Hospital of Shandong University,Jinan,Shandong,250012,China,1
NCT04305457,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Nitric Oxide,"Nitric Oxide (NO) will be delivered together with the standard of care for a period of 20-30 minutes 2 times per day for 14 consecutive days from time of enrollment. Targeted No inhaled concentration will be maintained between 140 and 180 ppm. The gas will be delivered through a CPAP circuit ensuring an end-expiratory pressure between 2 and 10 cmH2O or through a non-rebreathing mask without positive end-expiratory pressure, depending on the clinical needs of the patient.",NA,NA,NA,NA,NA,NA,NA
NCT04304690,"ClinicalTrials.gov processed this data on March 23, 2020",Other,blood sample,2 blood samples at T0 and 3 months,Recruiting,Hopital PitiÃ© SalpetriÃ¨re,Paris,,75013,France,1
NCT04307693,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Lopinavir/ritonavir,Lopinavir / Ritonavir tablet,Recruiting,"Asan Medical Center, University of Ulsan College of Medicine",Seoul,,138-736,"Korea, Republic of",1
NCT04307693,"ClinicalTrials.gov processed this data on March 20, 2020",Drug,Hydroxychloroquine sulfate,Hydroxychloroquine sulfate tablet,Recruiting,"Asan Medical Center, University of Ulsan College of Medicine",Seoul,,138-736,"Korea, Republic of",1
NCT04306393,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Nitric Oxide Gas,"80 ppm of inhaled nitric oxide for 48 hours, followed by 40 ppm, followed by weaning before stop.
Weaning criteria: maintenance of a PaO2/FiO2 ratio >/= 300 for at least 24 hours consecutively.",NA,NA,NA,NA,NA,NA,NA
NCT04308668,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Hydroxychloroquine,"200mg tablet; 800 mg orally once, followed in 6 to 8 hours by 600 mg, then 600mg once a day for 4 consecutive days",Recruiting,University of Minnesota,Minneapolis,Minnesota,55455,United States,1
NCT04308668,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Placebo,"4 placebo tablets once, followed in 6 to 8 hours by 3 tablets, then 3 tablets once-a-day for 4 consecutive days",Recruiting,University of Minnesota,Minneapolis,Minnesota,55455,United States,1
NCT04316377,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Hydroxychloroquine Sulfate,400 mg hydroxychloroquine sulphate (equalling 310 mg base) twice daily for seven days,NA,NA,NA,NA,NA,NA,NA
NCT04315948,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Remdesivir,"The lyophilized formulation of Remdesivir is a preservative-free, white to off-white or yellow, lyophilized solid containing 150 mg of Remdesivir to be reconstituted with 29 mL of sterile water for injection and diluted into IV infusion fluids prior to IV infusion. Following reconstitution, each vial contains a 5 mg/mL Remdesivir concentrated solution with sufficient volume to allow withdrawal of 30 mL (150 mg of Remdesivir). It is supplied as a sterile product in a single-use, 50 mL, Type 1 clear glass vial.",NA,NA,NA,NA,NA,NA,NA
NCT04315948,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Lopinavir/ritonavir,"The oral tablets of lopinavir/ritonavir contain 200 mg lopinavir, 50 mg ritonavir. They have a yellow colour, film-coated, ovaloid shape debossed with the ""a"" logo and the code KA. The oral solution for patients who cannot swallow is a light yellow to orange colored liquid containing 400 mg lopinavir and 100 mg ritonavir per 5 mL (80 mg lopinavir and 20 mg ritonavir per mL).",NA,NA,NA,NA,NA,NA,NA
NCT04315948,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Interferon Beta-1A,"IFN-ÃŸ-1a is supplied as a sterile solution containing no preservative available in a prefilled syringe. It will be provided as a single-dose prefilled graduated syringe with 44 Âµg per 0.5 mL. The liquid should be clear to slightly yellow. Do not use if the liquid is cloudy, discolored or contains particles. Use a different syringe.",NA,NA,NA,NA,NA,NA,NA
NCT04315948,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Standard of care,Standard of care.,NA,NA,NA,NA,NA,NA,NA
NCT04312009,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Losartan,Losartan; 25 mg daily; oral administration,||,Hennepin County Medical Center|M Health Fairview University of Minnesota Medical Center|University of Minnesota,Minneapolis|Minneapolis|Minneapolis,Minnesota|Minnesota|Minnesota,55415|55455|55455,United States|United States|United States,3
NCT04312009,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Placebo,"Placebo (microcrystalline methylcellulose, gelatin capsule); oral administration",||,Hennepin County Medical Center|M Health Fairview University of Minnesota Medical Center|University of Minnesota,Minneapolis|Minneapolis|Minneapolis,Minnesota|Minnesota|Minnesota,55415|55455|55455,United States|United States|United States,3
NCT04311177,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Losartan,Losartan; 25 mg daily; oral administration,||,Hennepin County Medical Center|M Health Fairview University of Minnesota Medical Center|University of Minnesota,Minneapolis|Minneapolis|Minneapolis,Minnesota|Minnesota|Minnesota,55415|55455|55455,United States|United States|United States,3
NCT04311177,"ClinicalTrials.gov processed this data on March 23, 2020",Other,Placebo,"Placebo (microcrystalline methylcellulose, gelatin capsule); oral administration",||,Hennepin County Medical Center|M Health Fairview University of Minnesota Medical Center|University of Minnesota,Minneapolis|Minneapolis|Minneapolis,Minnesota|Minnesota|Minnesota,55415|55455|55455,United States|United States|United States,3
NCT04316728,"ClinicalTrials.gov processed this data on March 23, 2020",Device,VivaDiagâ„¢ COVID-19 lgM/IgG Rapid Test,"VivaDiagâ„¢ COVID-19 lgM/IgG Rapid Test is an in vitro diagnostic for the qualitative determination of COVID-19 IgM and IgG antibodies in human whole blood (from vein or fingertip), serum or plasma",,"UnitÃ ' Complesse di cure primarie (UCCP), ASP Catanzaro",Catanzaro,,88100,Italy,1
NCT04315480,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Tocilizumab,single intravenous administration 8mg/Kg,,UniversitÃ  Politecnica delle Marche,Ancona,AN,60020,Italy,1
NCT04311697,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Aviptadil by intravenous infusion,Aviptadil by intravenous infusion,|,Research Facility|Rambam Health Care Campus,New York|Haifa,New York|,10016|3109601,United States|Israel,2
NCT04311697,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Aviptadil by endotracheal nebulization,Aviptadil by endotracheal nebulization,|,Research Facility|Rambam Health Care Campus,New York|Haifa,New York|,10016|3109601,United States|Israel,2
NCT04315298,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Sarilumab,Single intravenous (IV) dose of sarilumab,Recruiting,Regeneron Study Site,New York,New York,10029,United States,1
NCT04315298,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo,Single intravenous (IV) dose of placebo to match sarilumab administration,Recruiting,Regeneron Study Site,New York,New York,10029,United States,1
NCT04313322,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,WJ-MSCs,"WJ-MSCs will be derived from cord tissue of newborns, screened for HIV1/2, HBV, HCV, CMV, Mycoplasma, and cultured to enrich for MSCs.
WJ-MSCs will be counted and suspended in 25 ml of Saline solution containing 0.5% human serum Albumin, and will be given to patient intravenously.",Recruiting,Stem Cells Arabia,Amman,,11953,Jordan,1
NCT04313127,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),Intramuscular other name:Ad5-nCoV,NA,NA,NA,NA,NA,NA,NA
NCT04312243,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Inhaled nitric oxide gas,"Observational group: a SARS-CoV2 rt-PCR will be performed if symptoms arise. Treatment group: the subjects will breathe NO at the beginning of the shift and before leaving the hospital. Inspired NO will be delivered at 160 parts per million (ppm) for 15 minutes in each cycle. A SARS-CoV-2 rt-PCR will be performed if symptoms arise. Safety: Oxygenation and methemoglobin levels will be monitored via a non-invasive CO-oximeter. If methemoglobin levels rise above 5% at any point of the gas delivery, inhaled NO will be halvened. NO2 gas will be monitored and maintained below 5 ppm.",NA,NA,NA,NA,NA,NA,NA
NCT04310865,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Yinhu Qingwen Granula,"Yinhu Qingwen Granula is a kind of herbal granula made from ""Yinhu Qingwen Decoction"", which consits of 11 Chinese herbal medicine as Honeysuckle, Polygonum cuspidatum, Schizonepeta, Longspur epimedium, etc. The granula will be dissolved into 600ml decoction and divided to 3 times (once with 200ml). It will be given a 200ml per time, three times a day, for 10 days.",|||,Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University,Wuhan|Wuhan|Wuhan|Wuhan,Hubei|Hubei|Hubei|Hubei,430071|430071|430071|430200,China|China|China|China,4
NCT04310865,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Yin Hu Qing Wen Granula(low does),This intervention is given as 10% dose of YinHu QingWen Granula.The granula will be dissolved into 600ml decoction and divided to 3 times (once with 200ml).,|||,Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University,Wuhan|Wuhan|Wuhan|Wuhan,Hubei|Hubei|Hubei|Hubei,430071|430071|430071|430200,China|China|China|China,4
NCT04310865,"ClinicalTrials.gov processed this data on March 23, 2020",Other,standard medical treatment,Standard medical treatment is adhered to the protocol of the treatment for the severe CoVID-19 according to the guideline approved by National Health Commission of China.,|||,Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University,Wuhan|Wuhan|Wuhan|Wuhan,Hubei|Hubei|Hubei|Hubei,430071|430071|430071|430200,China|China|China|China,4
NCT04313023,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,PUL-042 Inhalation Solution,"20.3 Âµg Pam2 : 29.8 Âµg ODN/mL (50 Âµg PUL-042) PUL-042 Inhalation Solution will be given by nebulization on study days 1, 3, 6, and 10",NA,NA,NA,NA,NA,NA,NA
NCT04313023,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo,Sterile normal saline for inhalation,NA,NA,NA,NA,NA,NA,NA
NCT04312997,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,PUL-042 Inhalation Solution,"20.3 Âµg Pam2 : 29.8 Âµg ODN/mL (50 Âµg PUL-042) given by nebulization on study days 1, 3 and 6",,Houston Methodist Hospital,Houston,Texas,77030,United States,1
NCT04312997,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo,Sterile normal saline for inhalation,,Houston Methodist Hospital,Houston,Texas,77030,United States,1
NCT04315987,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,NestCellÂ®,"Phase 1 of the study: 6 patients will receive conventional treatment plus 3 times of 1x10^6 cells /kg body weight of NestCellÂ® intravenously on Day1, Day3 and Day7",NA,NA,NA,NA,NA,NA,NA
NCT04315987,"ClinicalTrials.gov processed this data on March 23, 2020",Biological,NestCellÂ®,"Phase 2 of the study: After Safety Monitoring Board evaluation, 18 patients will receive conventional treatment plus the dose and posology of NestCellÂ® recommended by Board.",NA,NA,NA,NA,NA,NA,NA
NCT04315896,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Hydroxychloroquine,hydroxychloroquine 400mg day for 10 days,NA,NA,NA,NA,NA,NA,NA
NCT04315896,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo oral tablet,Placebo oral tablet,NA,NA,NA,NA,NA,NA,NA
NCT04318015,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Hydroxychloroquine,All treatment will be administered orally.,NA,NA,NA,NA,NA,NA,NA
NCT04318015,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo oral tablet,All placebo will be administered orally,NA,NA,NA,NA,NA,NA,NA
NCT04317092,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Tocilizumab Injection,"Tocilizumab 8 mg/kg (up to a maximum of 800mg per dose), with an interval of 12 hours.",Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Not yet recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Azienda Ospedaliera ""SS. Antonio e Biagio e C. Arrigo"" (Dipartimento Internistico SSD Reumatologia)|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive)|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza)|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O.|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive)|ASST OVEST MILANESE presidi Legnano - Magenta|Azienda Ospedaliero-Universitaria di Modena|A.O.U. di Modena (Dipartimento Chirurgie Generali e SpecialitÃ  Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I)|A.O.U. di Modena (Dipartimento Chirurgie Generali e SpecialitÃ  Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II)|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive)|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia)|National Cancer Institute|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva)|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio)|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza)|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione)|Grande Ospedale Metropolitano, Reggio Calabria|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive)|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche)|ASST Sette Laghi (Dipartimento di Medicina Interna)|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze)|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale)|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali)|A.O.U. Integrata di Verona (Dip. Malattie Infettive)|Ospedale Magalini (U.O. Malattie Infettive)",Alessandria|Busto Arsizio|Catania|Catania|Cosenza|Magenta|Modena|Modena|Modena|Modena|Modena|Naples|Naples|Naples|Naples|Pesaro|Pozzuoli|Ravenna|Reggio Calabria|Rimini|Rome|Varese|Varese|Varese|Varese|Verona|Villafranca Di Verona,||||||||||||||||||||||||||,||||||42100|||||80131|80131||||||||||||||,Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy,27
NCT04317040,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,CD24Fc,CD24Fc is given on Day 1.,,"Institute of Human Virology, University of Maryland Baltimore",Baltimore,Maryland,21201,United States,1
NCT04317040,"ClinicalTrials.gov processed this data on March 23, 2020",Drug,Placebo,Placebo is given on Day 1.,,"Institute of Human Virology, University of Maryland Baltimore",Baltimore,Maryland,21201,United States,1
